Global Awareness & Prevention: Strategies & Impact

Okay, hear’s a summary of the provided text, focusing ⁢on the key takeaways regarding sexual health news⁣ and‍ initiatives:

Key themes & Details:

WHO ⁢& ⁣Sexual ⁤Health measurement: The World Health Association (WHO) is actively working to improve how countries measure and monitor sexual⁢ health outcomes, specifically through the advancement ⁣of the SHAPE questionnaire. This highlights the importance of⁢ sexual health in infectious disease prevention and care.
Aging with HIV: People living with HIV (PLWHIV) are living longer due to antiretroviral therapy (ART), but this brings new‍ health challenges. They are at higher risk ⁣for comorbidities like cardiovascular disease, metabolic syndrome, kidney⁤ problems, cognitive decline, and frailty. Clinicians need to proactively screen ‍for these issues and provide specialized,⁤ multidisciplinary care. New Gonorrhea Treatment Potential: The FDA has granted priority review to gepotidacin, a new oral antibiotic for uncomplicated gonorrhea. Clinical trials showed it to be non-inferior to the current standard treatment (ceftriaxone + azithromycin) and had a good safety profile. Approval would offer a much-needed new treatment option.
New HIV Treatment⁣ Regimen Under Review: Merck’s doravirine/islatravir (DOR/ISL),a once-daily two-drug HIV regimen,is under FDA review. Trials suggest‍ it’s effective for maintaining ⁢viral suppression in people who switch from existing treatments, with a PDUFA date of April 28, 2026.

In essence, ⁣the text showcases progress ⁢in both treating existing sexually transmitted infections (STIs) and managing the long-term health of individuals with HIV, alongside a broader⁢ effort to improve sexual health monitoring⁣ globally.